NCT00318175View on ClinicalTrials.gov

Effect of Bosentan on Skin Fibrosis in Patients With Systemic Sclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2006

Study Completion Date

May 31, 2007

Conditions
Systemic SclerodermaSkin FibrosisHand Functionality
Interventions
DRUG

Bosentan (Tracleer)

Trial Locations (1)

40225

Heinrich-Heine-University of Duesseldorf, Department of Dermatology, Düsseldorf

All Listed Sponsors
lead

Heinrich-Heine University, Duesseldorf

OTHER

NCT00318175 - Effect of Bosentan on Skin Fibrosis in Patients With Systemic Sclerosis | Biotech Hunter | Biotech Hunter